Conclusion Glucagon-like peptide-1 receptor agonists modulate key pathways in human mesenchymal stem cells to influence survival, differentiation, and metabolic function, suggesting promising therapeutic potential beyond glycemic control
Are some diets more beneficial than others
10.2337/dc17-0417 4 AhrnB.Leguizamo DimasA.MiossecP.SaubaduS.AronsonR
Patient assistance programs provide more sustainable solutions for managing medication costs
Many ongoing clinical trials, which evaluate clinical efficacy of NASH/NAFLD, are using imaging modalities using MRI-PDFF/MRE, which will become an alternative to liver biopsy
Tirzepatide, with its 5-day half-life, requires approximately 5 weeks of washout